Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function

Dettagli Bibliografici
Autori principali:	Hardman, C, Chen, W, Luo, J, Batty, P, Chen, Y, Nahler, J, Wu, Y, Pavord, I, Erpenbeck, V, Sandham, D, Xue, L, Ogg, G
Natura:	Journal article
Pubblicazione:	Elsevier 2019

Documenti analoghi

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
di: Chen, W, et al.
Pubblicazione: (2018)

Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
di: Xue, L, et al.
Pubblicazione: (2018)

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
di: Sandham, D, et al.
Pubblicazione: (2019)

Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
di: Xue, L, et al.
Pubblicazione: (2019)

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells
di: Luo, J, et al.
Pubblicazione: (2019)

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
di: Veit J. Erpenbeck, et al.
Pubblicazione: (2016-12-01)

Investigating functions of human group 2 innate lymphoid cells in health and disease
di: Nahler, J
Pubblicazione: (2021)

IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
di: Hardman, CS, et al.
Pubblicazione: (2021)

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial
di: Gonem, S, et al.
Pubblicazione: (2016)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells
di: Xue, L, et al.
Pubblicazione: (2013)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.
di: Xue, L, et al.
Pubblicazione: (2014)

Cytometric gating stringency impacts on studies of type 2 innate lymphoid cells in asthma
di: Hinks, T, et al.
Pubblicazione: (2017)

The prostaglandin D2 receptor 2 pathway in asthma: a key player in airway inflammation
di: Christian Domingo, et al.
Pubblicazione: (2018-09-01)

The roles of type 2 cytotoxic T cells in inflammation, tissue remodeling, and prostaglandin (PG) D2 production are attenuated by PGD2 receptor 2 antagonism
di: Chen, W, et al.
Pubblicazione: (2021)

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells
di: Hardman, C, et al.
Pubblicazione: (2017)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
di: Ogg, G, et al.
Pubblicazione: (2015)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
di: Salimi, M, et al.
Pubblicazione: (2015)

Prostaglandin D2 receptor 2 downstream signaling and modulation of type 2 innate lymphoid cells from patients with asthma.
di: Christina Gress, et al.
Pubblicazione: (2024-01-01)

Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism
di: Saunders, R, et al.
Pubblicazione: (2017)

Fevipiprant reduced airway smooth muscle massin asthmatics via PGD2Receptor antagonism
di: Saunders, R, et al.
Pubblicazione: (2017)

The role of type 2 innate lymphoid cells in the pathogenesis of atopic dermatitis
di: Salimi, M, et al.
Pubblicazione: (2014)

Group 2 innate lymphoid cells and asthma
di: Hiroki Kabata, et al.
Pubblicazione: (2015-07-01)

Bronchoprotective role for endogenous prostaglandin E2.
di: Pavord, I, et al.
Pubblicazione: (1995)

The role of peripheral type 2 innate lymphoid cells in bronchiolitis
di: Yong-Jun Tang, et al.
Pubblicazione: (2021-01-01)

Group 2 Innate Lymphoid Cells in Allergic Rhinitis
di: Wang S, et al.
Pubblicazione: (2024-11-01)

Group 2 innate lymphoid cells and their surrounding environment
di: Maiko Naito, et al.
Pubblicazione: (2023-03-01)

Group 2 innate lymphoid cells in human asthma
di: Arifumi Iwata, et al.
Pubblicazione: (2023-04-01)

The Fate of Activated Group 2 Innate Lymphoid Cells
di: Laura Mathä, et al.
Pubblicazione: (2021-04-01)

Prostaglandin E2 Inhibits Group 2 Innate Lymphoid Cell Activation and Allergic Airway Inflammation Through E-Prostanoid 4-Cyclic Adenosine Monophosphate Signaling
di: Yu Zhou, et al.
Pubblicazione: (2018-03-01)

Type 2 Innate Lymphoid Cells: Protectors in Type 2 Diabetes
di: Jacob D. Painter, et al.
Pubblicazione: (2021-08-01)

Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.
di: Armer, R, et al.
Pubblicazione: (2005)

Cysteinyl leukotriene E4 activates human ILC2s and enhances the effect of prostaglandin D2 and epithelial cytokines
di: Salimi, M, et al.
Pubblicazione: (2017)

Dengue virus co-opts innate type 2 pathways to escape early control of viral replication
di: Chathuranga L. Fonseka, et al.
Pubblicazione: (2022-07-01)

Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs
di: Christophe Pellefigues, et al.
Pubblicazione: (2018-02-01)

MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion.
di: Oliphant, C, et al.
Pubblicazione: (2016)

Type-2 innate lymphoid cells control the development of atherosclerosis in mice
di: Stephen A. Newland, et al.
Pubblicazione: (2017-06-01)

The Functional Role of Group 2 Innate Lymphoid Cells in Asthma
di: Takahiro Matsuyama, et al.
Pubblicazione: (2023-05-01)

Tissue Resident and Migratory Group 2 Innate Lymphoid Cells
di: Laura Mathä, et al.
Pubblicazione: (2022-04-01)

Group 2 Innate Lymphoid Cells in Respiratory Allergic Inflammation
di: Sofia Helfrich, et al.
Pubblicazione: (2019-06-01)

The Role of Type 2 Innate Lymphoid Cells in Allergic Diseases
di: Haocheng Zheng, et al.
Pubblicazione: (2021-06-01)